| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.2M | +42.0% |
| SG&A Expense | $9.6M | +1505.5% |
| Net Income | -$16.5M | -26.5% |
| EPS (Basic) | $0.56 | +216.7% |
| EPS (Diluted) | $0.56 | +224.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $1.3M | +204.2% |
| Total Assets | $1.3M | -72.3% |
| Current Liabilities | $681K | -49.0% |
| Total Liabilities | $681K | -49.0% |
| Stockholders' Equity | $643K | -81.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -31.4% |
| Financing Cash Flow | $6.3M | +64.1% |